Cite
HARVARD Citation
Denton, C. et al. (2018). Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Annals of the rheumatic diseases. 77 (9), pp. 1362-1371. [Online].